Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 41 Records) |
Query Trace: Hypertension and CYP2C19[original query] |
---|
Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention. European journal of clinical pharmacology 2017 Jun . Ol?dzki Szymon, Kornacewicz-Jach Zdzis?awa, Safranow Krzysztof, Kiedrowicz Rados?aw, Gawro?ska-Szklarz Barbara, Jastrz?bska Maria, Gor?cy Jaros? |
Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China. European journal of clinical pharmacology 2018 Apr 74 (4): 423-431. Zhong Zhixiong, Hou Jingyuan, Zhang Qifeng, Li Bin, Li Cunren, Liu Zhidong, Yang Min, Zhong Wei, He Xuebo, Wu Hesen, Zhong Miaocai, Zhao Pings |
Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population. Oncotarget 2017 Sep 8 (41): 70811-70820. Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Ju, Zhou Qia |
Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis. The Korean journal of internal medicine 2018 6 34 (5): 1022-1029. Chang Young Woon, Ko Weon Jin, Oh Chi Hyuk, Park Yoo Min, Oh Shin Ju, Moon Jung Rock, Cho Jun-Hyung, Kim Jung-Wook, Jang Jae-You |
Polymorphisms in CYP450 Genes and the Therapeutic Effect of Atorvastatin on Ischemic Stroke: A Retrospective Cohort Study in Chinese Population. Clinical therapeutics 2018 Feb . Peng Chen, Ding Ying, Yi Xin, Shen Yupei, Dong Zhiqiang, Cao Limei, Li Qiang, Ren Haiyan, He Lin, Zhou Daizhan, Chen |
CYP2C19 Genotype is an Independent Predictor of Adverse Cardiovascular Outcome in Iraqi Patients on Clopidogrel After Percutaneous Coronary Intervention. Journal of cardiovascular pharmacology 2018 Mar . Mohammad Ameen M, Al-Allawi Nasir A |
Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease. Journal of personalized medicine 2018 Jan 8 (1): . Cacabelos Ramón, Meyyazhagan Arun, Carril Juan C, Cacabelos Pablo, Teijido Ósc |
Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects. Pharmacogenomics and personalized medicine 2019 12 329-339. Dorofeeva Margarita N, Shikh Evgenia V, Sizova Zhanna M, Tarasenko Alisa V, Denisenko Natalia P, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Grishina Elena A, Sychev Dmitriy |
Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study. BMC cardiovascular disorders 2021 Aug 21 (1): 391. Yu Luhai, Wang Tingting, Bai Huidong, Zhu Weijiang, Li Yanju, Wu Jianhua, Liu Wenli, Sun Li, Yu Aiping, Li Hongji |
The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention. European journal of clinical pharmacology 2021 6 77 (11): 1679-1686. Wang Tingting, Li Hongjian, Wang Fengxia, Sun Li, Yu Luh |
CYP2C19 Loss-of-Function Associated with First-Time Ischemic Stroke in Non-surgical Asymptomatic Carotid Artery Stenosis During Clopidogrel Therapy. Translational stroke research 2021 2 13 (1): 46-55. Patel Pious D, Niu Xinnan, Shannon Chevis N, Denny Joshua C, Peterson Josh F, Fusco Matthew R, Chitale Rohan |
Clinical and Pharmacological Parameters Determine Relapse During Clopidogrel Treatment of Acute Coronary Syndrome. Journal of clinical pharmacology 2021 12 62 (6): 783-791. Santana-Mateos Marta, Medina-Gil José M, Saavedra-Santana Pedro, Martínez-Quintana Efrén, Rodríguez-González Fayna, Tugores Anton |
Derivation of a Novel Scoring System Predicting High Platelet Reactivity on Prasugrel in Patients with Coronary Artery Disease. Journal of atherosclerosis and thrombosis 2021 12 29 (11): 1625-1633. Saito Yuichi, Nishi Takeshi, Wakabayashi Shinichi, Ohno Yuji, Kitahara Hideki, Ariyoshi Noritaka, Kobayashi Yosh |
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study. European journal of clinical pharmacology 2021 Oct . Mer?ep Iveta, Radman Ivana, Trkulja Vladimir, Božina Tamara, Šimi?evi? Livija, Budimir Ema, Ganoci Lana, Božina Na |
Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers in pharmacology 2022 13 918219. Tan Tingfei, Han Gongwei, Cheng Ziwei, Jiang Jiemei, Zhang Li, Xia Zitong, Wang Xinmeng, Xia Qu |
Relationship between recurrent ischemic events in cerebrovascular disease and cytochrome P450 2C19 gene polymorphism on the basis of thrombelastography. Annals of palliative medicine 2022 Jan 11 (1): 240-249. Liu Jiaming, Zhao Yulong, Chen He, Yang Fangyu, Chen Ligang, Hao Guangzhi, Gao |
Nutritional and genetic determinants of essential hypertension among adult respondents of the 2013 national nutrition survey, Philippines: a preliminary observational study. The Journal of nutritional biochemistry 2022 10 110 109152. Zumaraga Mark Pretzel P, Rodriguez Marietta P, Aman Aimee Yvonne Criselle, Deguit Christian Deo T, Biwang Jessica H, Melegrito Jodelyn B, Duante Charmaine A, Madrid Marilou L, Concepcion Mae Anne R, Nevado Jose |
CYP2C19 polymorphisms and clopidogrel efficacy in the secondary prevention of ischemic stroke: a retrospective observational study. Annals of palliative medicine 2022 1 10 (12): 12171-12180. Lin Juanna, Mo You, Cai De, Mao Dongyang, Fu Hongbo, Wei Dunc |
CYP2C19 Loss-of-Function Variants Associated with Long-term Ischemic Stroke Events During Clopidogrel Treatment in the Chinese Population. Clinical pharmacology and therapeutics 2023 8 . Peng Wu, Ziqing Liu, Zijian Tian, Benrui Wu, Jian Shao, Qian Li, Zhaoxu Geng, Ying Pan, Ke Lu, Qiang Wang, Tao Xu, Kaixin Zh |
Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients. International journal of general medicine 2023 8 16 3473-3481. Yuliang Shi, Yuxian Yang, Miaoling Feng, Weihan Ling, Tongguo Wei, Yumin Cao, Rui Zhong, Heming |
Use of Tirofiban to Prevent Ischemic Events in Patients with CYP2C19 Loss-of-Function Alleles during Flow Diversion of Intracranial Aneurysm: A Multicenter Cohort Study. Translational stroke research 2023 7 . Yangyang Zhou, Huibin Kang, Wenqiang Li, Bin Luo, Chao Wang, Ruhang Xie, Yongnan Zhu, Qichen Peng, Yisen Zhang, Jian Liu, Ying Zhang, Shiqing Mu, Sheng Guan, Wenfeng Feng, Xinjian Ya |
Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension. Placenta 2023 5 137 88-95. Mert C Ongun, Nazan Vanli Tonyali, Ozan Kaplan, Ilter Deger, Mustafa Celebier, Nursabah E Basci Akduman, Dilek Sahin, Aykan Yucel, Melih O Babaog |
Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study. Pharmaceuticals (Basel, Switzerland) 2023 5 16 (5): . Ana Batinic, Davorka Sutlovi?, Sendi Kuret, Antonela Matana, Marko Kumric, Josko Bozic, Zeljko Duj |
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt. Journal of epidemiology and global health 2023 5 . Ahmed Shawky, Hussein Sabit, Mahmoud Nazih, Khalid Baraka, Mokhtar El-Zawah |
CYP2C19 loss-of-function is associated with increased risk of hypertension in a Hakka population: a case-control study. BMC cardiovascular disorders 2023 4 23 (1): 185. Cai Nan, Li Cunren, Gu Xianfang, Zeng Wenfeng, Zhong Jiawei, Liu Jingfeng, Zeng Guopeng, Zhu Junxing, Hong Haife |
Association of CYP2C19 Polymorphic Markers with Cardiovascular Disease Risk Factors in Gas Industry Workers Undergoing Periodic Medical Examinations. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2023 2 . Sychev Dmitry Alekseevich, Polyakova Olga Alexandrovna, Sozaeva Zhannet Alimovna, Mirzaev Karin Badavievich, Ostroumova Olga Dmitriev |
CYP2C19 *2/*2 Genotype is a Risk Factor for Multi-Site Arteriosclerosis: A Hospital-Based Cohort Study. International journal of general medicine 2023 11 16 5139-5146. Jieyao Xie, Tingjun Pan, Weiwen Luo, Songsheng Zhang, Yuquan Fang, Zhou |
High Frequency of CYP2C19*3 Heterozygotes Among Patients Under Clopidogrel Treatment in Ouagadougou, Burkina Faso. Pakistan journal of biological sciences : PJBS 2024 9 27 (8): 398-403. Abdoul Karim Ouattara, Yves Donald Kagambega, Teega-Wende Clarisse Ouedraogo, Lassina Traore, Modeste Ouedraogo, Nobila Valentin Yameogo, Jacques Simpo |
CYP2C19 loss-of-function variants are independent risk factors for premature cerebral infarction: a hospital based retrospective study. BMC cardiovascular disorders 2024 10 24 (1): 602. Yuliang Shi, Yuxian Yang, Miaoling Feng, Heming |
Relationships of Proton Pump Inhibitor-Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study. Clinical pharmacology and therapeutics 2024 1 . Rika Fukui, Satoshi Noda, Yoshito Ikeda, Yuichi Sawayama, Tomohiro Terada, Yoshihisa Nakagawa, Shin-Ya Mori |
- Page last reviewed:Feb 1, 2024
- Content source: